Name: Imbue GLP-1 Telehealth Membership — Lowest Fee in Industry
Brand: Imbue Health
Price: 29.00 USD
Availability: InStock

Question 1

Is Imbue Health legit?

Accepted Answer

Yes. Imbue Health is LegitScript Healthcare Merchant Certified — the same third-party vetting standard Google and Meta require of telehealth advertisers — HIPAA-compliant, and care is delivered through licensed medical practices (Cyane Medical Group) with U.S.-licensed physicians in all 50 states and Washington, D.C. We prescribe only FDA-approved brand-name GLP-1 medications (Foundayo™, Wegovy®, Oral Wegovy®, Zepbound®), dispensed by the manufacturers' own pharmacy programs, NovoCare and LillyDirect — never compounded substitutes.

Question 2

How fast can I get a GLP-1 prescription?

Accepted Answer

Most patients go from consultation to medication in about 48 hours. The online health assessment takes about 5 minutes, a licensed physician reviews your profile — typically within 24 hours — and once prescribed, your medication ships directly from NovoCare or LillyDirect. You are only charged the $29/month membership if a provider confirms you're a candidate.

Question 3

Does Imbue Health take insurance?

Accepted Answer

The $29/month membership is cash-pay by design — no insurance paperwork required — and most patients purchase medication at the manufacturer's published cash-pay price (from $149/month) through NovoCare or LillyDirect. One important exception: Imbue utilizes the Medicare GLP-1 Bridge Program for eligible Medicare patients. Your physician sends the prescription to the manufacturer pharmacy, the pharmacy initiates the prior authorization with your Medicare plan, and approved patients pay a fixed $50/month for medication — $79/month all-in with membership, the lowest total cost in the industry.

Question 4

I'm on Medicare — can I use Imbue?

Accepted Answer

Yes. Imbue actively utilizes the Medicare GLP-1 Bridge Program. If you meet the program's clinical criteria (BMI 35+; or BMI 30+ with heart failure with preserved ejection fraction, uncontrolled high blood pressure — above 140 systolic or 90 diastolic despite two blood-pressure medications — or chronic kidney disease stage 3a+; or BMI 27+ with a history of pre-diabetes, heart attack, stroke, or symptomatic peripheral artery disease), your medication is a fixed $50/month: all doses of Wegovy® — pen and pill — through NovoCare, or Zepbound® KwikPen and Foundayo™ through LillyDirect. The pharmacy initiates the prior authorization for you. See tryimbue.com/medicare-glp1 for details.

Question 5

Can I switch to Imbue from Hims, Ro, or another telehealth provider?

Accepted Answer

Yes — many of our patients switch from other platforms to lower their membership cost. Because Imbue prescribes the same FDA-approved brand-name medications, treatment continues seamlessly: complete the intake, tell your Imbue physician your current medication and dose, and they take over your care. See our side-by-side provider comparisons at tryimbue.com/compare.

Question 6

Does Imbue prescribe compounded semaglutide or tirzepatide?

Accepted Answer

Never. Imbue prescribes exclusively FDA-approved, brand-name GLP-1 medication shipped from manufacturer pharmacies. Compounded GLP-1 copies are not FDA-approved, and with the FDA's shortage resolutions they are being phased out industry-wide. If you want the lowest legitimate price on real Wegovy®, Zepbound®, Oral Wegovy®, or Foundayo™ — that is exactly what Imbue is built for.

Question 7

How does Imbue Health work?

Accepted Answer

Imbue Health provides online consultations with licensed medical providers who can prescribe GLP-1 medications for weight loss. Complete a brief health questionnaire, get evaluated by a provider, and if appropriate, receive your medication delivered to your door.

Question 8

How long does the consultation process take?

Accepted Answer

The initial health questionnaire takes about 5-10 minutes. A licensed provider typically reviews your information within 24 hours. If approved, your medication ships within 1-2 business days.

Question 9

Do I need to see a doctor in person?

Accepted Answer

No. Imbue Health is a telehealth service, so all consultations happen online. You'll communicate with your provider through our secure messaging platform. If your provider determines you need in-person care, they'll let you know.

Question 10

What states do you operate in?

Accepted Answer

Imbue Health is licensed to provide telehealth services in all 50 US states and Washington, D.C. During signup, we'll verify your state of residence to connect you with an appropriately licensed provider.

Question 11

How do I get started?

Accepted Answer

Click 'Get Started' to begin your health assessment. You'll answer questions about your medical history, current health, and weight loss goals. A provider will review your information and reach out with next steps.

Question 12

How much weight can I expect to lose?

Accepted Answer

Results vary by individual, but clinical trials show significant outcomes. Patients on Wegovy® lost an average of 15% of their body weight over 68 weeks, while patients on Zepbound® lost an average of 22% over 72 weeks. For a 250-pound patient, that translates to roughly 37–55 pounds. Your actual results will depend on factors like starting weight, dosage, diet, and activity level — your Imbue Health provider will help set realistic goals and monitor your progress.

Question 13

Is Imbue available for men and women?

Accepted Answer

Yes — Imbue serves all eligible adults (BMI ≥25 with a weight-related condition, or BMI ≥30) regardless of sex. Unlike sex-specific programs (Fella for men, Juniper/Reverse for women), Imbue offers identical pricing and the same full FDA-approved medication menu — Wegovy®, Zepbound®, and Foundayo™ — for any patient who qualifies.

Question 14

What GLP-1 medications do you prescribe?

Accepted Answer

We exclusively prescribe FDA-approved, brand-name GLP-1 medications: Foundayo™, Oral Wegovy®, injectable Wegovy®, Zepbound® Vials, and Zepbound® KwikPen. We do not prescribe compounded alternatives. Your provider will recommend the best option based on your health profile, preferences, and treatment goals.

Question 15

Do you prescribe Ozempic® or Mounjaro®?

Accepted Answer

No. Ozempic® and Mounjaro® are FDA-approved for type 2 diabetes, not weight loss. We prescribe their weight-loss-indicated counterparts: Wegovy® and Oral Wegovy® (same active ingredient as Ozempic® — semaglutide) and Zepbound® Vials and KwikPen (same active ingredient as Mounjaro® — tirzepatide). These medications are specifically FDA-approved for chronic weight management.

Question 16

Mounjaro® vs. Zepbound® — what's the difference?

Accepted Answer

Both contain tirzepatide. Mounjaro® is FDA-approved for type 2 diabetes; Zepbound® is FDA-approved for chronic weight management and obstructive sleep apnea. Imbue prescribes Zepbound® for weight-management patients (the on-label indication). Patients with type 2 diabetes seeking weight management may be candidates for Zepbound® rather than off-label Mounjaro®.

Question 17

Why does Imbue only prescribe brand-name medications?

Accepted Answer

We exclusively prescribe FDA-approved, brand-name medications from Novo Nordisk (Wegovy®, Oral Wegovy®) and Eli Lilly (Foundayo™, Zepbound® Vials, Zepbound® KwikPen) because they undergo rigorous FDA review for safety, efficacy, and manufacturing quality. While compounded versions may cost less, they don't have the same regulatory oversight. Our partnership with NovoCare and LillyDirect allows us to offer brand-name medications at competitive prices. See our full Brand-Name vs. Compounded guide for details.

Question 18

Why does Imbue not prescribe compounded semaglutide or tirzepatide?

Accepted Answer

With the FDA semaglutide and tirzepatide shortages resolved in 2025, the legal basis for compounding these molecules at scale has narrowed, and the FDA has issued warning letters to multiple telehealth providers for misleading claims about compounded GLP-1s. Compounded products have not undergone FDA review for safety, efficacy, or manufacturing quality. Imbue chose to prescribe only FDA-approved brand-name Wegovy®, Zepbound®, and Foundayo™ — at manufacturer cash-pay pricing that is now competitive with compounded alternatives. Read more.

Question 19

What's the difference between brand-name Wegovy® and compounded semaglutide?

Accepted Answer

Brand-name Wegovy® is the FDA-approved formulation of semaglutide, manufactured by Novo Nordisk under FDA oversight with full sterility testing, package insert, and recall pathway. Compounded semaglutide is mixed by a pharmacy and has not been reviewed by the FDA for safety, efficacy, sterility, or manufacturing consistency. Insurance covers only brand-name; compounded is cash-pay only.

Question 20

Zepbound® vs. Wegovy® — which works better?

Accepted Answer

In the SURMOUNT-5 head-to-head trial (NEJM 2025), tirzepatide (Zepbound®) produced 20.2% mean weight loss vs. 13.7% for semaglutide (Wegovy®) over 72 weeks. Tirzepatide's dual GIP/GLP-1 mechanism appears to drive the difference. Imbue prescribes both, and your physician will recommend based on medical history, side-effect tolerance, and cost.

Question 21

How do I know which medication is right for me?

Accepted Answer

Your provider will recommend a medication based on your health history, BMI, preferences (pill vs. injection), budget, and treatment goals. You can also express preferences during your consultation.

Question 22

How do you keep medication costs affordable?

Accepted Answer

Through our partnerships with NovoCare (Novo Nordisk) and LillyDirect (Eli Lilly), we help you access manufacturer savings programs that make brand-name medications more affordable—often comparable to or better than compounded alternatives, with FDA-approved quality and safety.

Question 23

What if there's a medication shortage?

Accepted Answer

GLP-1 medications occasionally experience shortages. We monitor supply closely across all our medication options (Foundayo™, Oral Wegovy®, injectable Wegovy®, Zepbound® Vials, and Zepbound® KwikPen) and will work with you to find an available FDA-approved alternative if your preferred medication is temporarily unavailable.

Question 24

Can I switch medications if one isn't working for me?

Accepted Answer

Yes. If you're experiencing issues with your current medication, message your provider to discuss alternatives. Switching medications is common and your provider will guide the transition.

Question 25

What is Oral Wegovy®?

Accepted Answer

Oral Wegovy® is the first FDA-approved GLP-1 pill for chronic weight management. It contains the same active ingredient (semaglutide) as injectable Wegovy® but is taken as a daily tablet instead of a weekly injection.

Question 26

How do I take Oral Wegovy®?

Accepted Answer

Take it first thing in the morning on an empty stomach with no more than 4 ounces of plain water. Wait at least 30 minutes before eating, drinking anything else, or taking other oral medications. Swallow the tablet whole — do not crush, chew, or split it.

Question 27

Is the oral GLP-1 pill as effective as the shot?

Accepted Answer

Oral GLP-1s now achieve weight-loss outcomes comparable to injectables (oral semaglutide 13.6% over 64 weeks; Foundayo™ 11.2% over 72 weeks; injectable Wegovy® 14.9–19% over 68 weeks; injectable Zepbound® up to 22.5% over 72 weeks). Injectables remain marginally more effective at maximum doses, but adherence is often higher with the pill. See our full Oral vs. Injectable guide.

Question 28

Foundayo™ vs. Oral Wegovy® — which oral GLP-1 should I choose?

Accepted Answer

Both are FDA-approved oral once-daily GLP-1s. Oral Wegovy® (oral semaglutide 25 mg) showed 13.6% mean weight loss at 64 weeks but must be taken on an empty stomach with ≤120 ml of water followed by a 30-minute fast. Foundayo™ (orforglipron 17.2 mg) showed 11.2% weight loss at 72 weeks and can be taken any time of day with or without food or water — making it more convenient for many patients. Imbue prescribes both.

Question 29

Can I switch from Wegovy® injection to the oral Wegovy® pill or to Foundayo™?

Accepted Answer

Yes, with provider supervision. Imbue physicians can transition you between Wegovy® injection, Oral Wegovy®, Zepbound®, and Foundayo™ based on tolerance, side effects, and lifestyle preferences. Your $29 monthly membership covers all medication switches and re-titration consultations.

Question 30

Can I switch from Oral Wegovy® to the injection?

Accepted Answer

Yes. If you'd prefer a once-weekly injection over a daily pill, your provider can transition you to injectable Wegovy®. Some patients prefer the simplicity of dosing once a week rather than daily.

Question 31

Are the side effects different from injectable Wegovy®?

Accepted Answer

The most common side effects — nausea, diarrhea, constipation, and decreased appetite — are similar. However, Oral Wegovy® may also cause oral-specific effects like difficulty swallowing, gastritis, or abdominal distension. These typically improve as your body adjusts. See our full Safety Information page for details.

Question 32

Why is Oral Wegovy® less expensive than the injectable?

Accepted Answer

Oral Wegovy® is priced starting at $149/month through NovoCare compared to $199/month for injectable Wegovy®. Pricing is set by Novo Nordisk through their savings program — the lower price point makes it an accessible entry point for patients starting GLP-1 treatment.

Question 33

Who is Oral Wegovy® a good fit for?

Accepted Answer

It's a strong option for patients who want to avoid injections, prefer a daily routine over a weekly one, or are looking for the most affordable brand-name GLP-1 option. Your provider will help determine if it's the right choice based on your health profile and preferences.

Question 34

What is Foundayo™?

Accepted Answer

Foundayo™ (orforglipron) is a once-daily oral GLP-1 pill approved by the FDA for chronic weight management. It's made by Eli Lilly and is the only GLP-1 pill that can be taken any time of day without food or water restrictions.

Question 35

Where can I get Foundayo™ (orforglipron) prescribed online?

Accepted Answer

Imbue prescribes Foundayo™ to eligible patients in all 50 states and Washington, D.C., dispensed by LillyDirect at $149/month cash-pay (lowest dose). Combined with the $29/month Imbue membership, total monthly cost starts at $178/month.

Question 36

How is Foundayo™ different from Oral Wegovy®?

Accepted Answer

Both are oral GLP-1 pills, but Foundayo™ can be taken at any time of day with no food or water restrictions. Oral Wegovy® must be taken first thing in the morning on an empty stomach, 30 minutes before eating or drinking. Foundayo™ is also a non-peptide small molecule (not a peptide like semaglutide), making it easier to manufacture.

Question 37

How do I take Foundayo™?

Accepted Answer

Take one tablet at any time of day — with or without food, with any beverage. There are no special timing requirements relative to meals or other medications. Swallow the tablet whole.

Question 38

How effective is Foundayo™ for weight loss?

Accepted Answer

In the ATTAIN-1 clinical trial, patients on the highest dose of Foundayo™ lost an average of about 11% of their body weight over 72 weeks, and more than half achieved at least 10% weight loss. While injectable options like Zepbound® (22%) show higher average weight loss, Foundayo™ offers the convenience of a daily pill with no restrictions.

Question 39

Can I switch from an injectable GLP-1 to Foundayo™?

Accepted Answer

Yes. The ATTAIN-MAINTAIN trial showed that patients switching from injectable Wegovy® or Zepbound® to Foundayo™ maintained their previously achieved weight loss. Your Imbue Health provider can help manage the transition.

Question 40

How much does Foundayo™ cost through Imbue?

Accepted Answer

Foundayo™ ships from LillyDirect at the manufacturer's published self-pay price — $149/month for the lowest dose for cash-pay patients. Imbue's flat $29/month membership covers the physician evaluation and ongoing care. Total starting cost: $178/month.

Question 41

Do I qualify for a GLP-1 prescription through Imbue?

Accepted Answer

You may qualify if you are 18+ with a BMI of 30 or greater (obesity), or 25 or greater (overweight) with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, sleep apnea, or cardiovascular disease. Imbue's $29 membership includes an eligibility check; if you don't qualify, you are not charged.

Question 42

Is Imbue available in all 50 states?

Accepted Answer

Yes — Imbue's professional corporation network is licensed to prescribe in all 50 states and Washington, D.C. Some compounded-only competitors are restricted in specific states (e.g., Mississippi, Alabama, North Dakota) due to state pharmacy compounding rules; Imbue avoids that constraint by prescribing exclusively brand-name FDA-approved medications shipped by Novo Nordisk and Eli Lilly, which are available in every state.

Question 43

What BMI do I need to qualify?

Accepted Answer

Generally, BMI ≥30 qualifies for treatment. BMI 25-29.9 may qualify if you have weight-related conditions. Note: FDA labels for Wegovy®, Zepbound®, and Foundayo™ list BMI ≥27 (with comorbidity) as the threshold, so prescribing in the BMI 25–26.9 range is off-label and offered at the provider's discretion based on your clinical picture. Your provider will evaluate your complete health profile, not just BMI.

Question 44

Can Imbue prescribe a GLP-1 if my BMI is below 25?

Accepted Answer

In select cases, yes — but at the provider's discretion. Your Imbue physician may consider prescribing for patients with BMI below 25 in the context of abnormal weight gain, weight regain after prior weight loss, or other significant weight-related health concerns, evaluated case-by-case after a complete clinical review. Off-label aesthetic prescribing is not part of our model.

Question 45

Can I get GLP-1 medications if I have type 2 diabetes?

Accepted Answer

Yes, many GLP-1 medications are also approved for type 2 diabetes. However, if you're already taking diabetes medications, your provider will need to review potential interactions and adjust dosing accordingly.

Question 46

What medical conditions might disqualify me?

Accepted Answer

Certain conditions may prevent GLP-1 use, including personal or family history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2 (MEN2), history of pancreatitis, or pregnancy/breastfeeding. Your provider will review your full history.

Question 47

Are your providers licensed?

Accepted Answer

Yes, all Imbue Health providers are US-licensed, board-certified physicians, nurse practitioners, or physician assistants. They're licensed in the state where you reside and specialize in weight management.

Question 48

Is there an age requirement?

Accepted Answer

You must be 18 or older to use Imbue Health services. GLP-1 medications are approved for adults only.

Question 49

What happens if I'm not approved?

Accepted Answer

If our provider determines that GLP-1 medication isn't right for you based on your health profile, you won't be charged for the membership. Your provider will explain why and, when possible, suggest alternative next steps. You're never locked in or charged before a prescribing decision is made.

Question 50

What is the safest, cheapest brand-name GLP-1 telehealth program in 2026?

Accepted Answer

For brand-name FDA-approved GLP-1s with no compounded substitutes, Imbue offers the lowest published membership ($29/month) of any major LegitScript-certified, 50-state telehealth provider. Medication ships at manufacturer cash-pay prices from NovoCare and LillyDirect. Total monthly cost starts at $178 — $29 membership plus $149 for an oral GLP-1 (Foundayo™ or Oral Wegovy®). Brand-name Wegovy® and Zepbound® start at $228 and $328/month all-in.

Question 51

What is the cheapest legitimate way to get brand-name Wegovy® without insurance in 2026?

Accepted Answer

Through Imbue, Wegovy® ships directly from NovoCare Pharmacy at the manufacturer's cash-pay price (from $199/month at the starting dose to $349/month for higher doses) plus a flat $29/month Imbue membership for physician care. Total starting cost: $228/month — among the lowest legitimate brand-name pathways in the U.S., with no compounded medication and no long-term contract.

Question 52

What is the real monthly cost of Wegovy® through Imbue?

Accepted Answer

From $228/month all-in at the starting dose ($29 Imbue + $199 NovoCare), up to $378/month for higher doses ($29 + $349 NovoCare). Imbue Health is a cash-pay program — though eligible Medicare patients can pay a fixed $50/month for medication through the Medicare GLP-1 Bridge Program ($79/month all-in).

Question 53

Why does Imbue separate the $29 membership from medication cost?

Accepted Answer

Most direct-to-consumer GLP-1 programs bundle medication into a single inflated monthly fee, which hides what you're paying for physician care versus drug. Imbue separates the two: $29/month covers your physician, prescription review, and ongoing support; your medication ships from NovoCare or LillyDirect at the same cash-pay price the manufacturer publishes. There is no introductory rate that escalates, no 12-month commitment, and no auto-renewing bundle.

Question 54

How much does an Imbue Health membership cost?

Accepted Answer

$29/mo. No introductory pricing that goes up later, no price hikes. Your membership covers physician consultations, ongoing clinical care, dosage adjustments, and prescription management. There are no contracts — cancel anytime.

Question 55

How much do the medications cost?

Accepted Answer

Medication is purchased separately through the manufacturer's savings program. Foundayo™ starts at $149/month via LillyDirect, Oral Wegovy® starts at $149/month via NovoCare, injectable Wegovy® starts at $199/month via NovoCare, and Zepbound® Vials and KwikPen start at $299/month via LillyDirect. These prices are independent of insurance.

Question 56

Is there a long-term commitment with Imbue?

Accepted Answer

No. Imbue is month-to-month — cancel any time by emailing support@tryimbue.com or via your account portal. There is no annual prepay, no 3-month minimum, and no cancellation fee. This contrasts with WeightWatchers Clinic ($49/mo with a $25 intro for 3 months), Fella Health ($165/mo only with 12-month prepay), and Calibrate (1-year metabolic reset program).

Question 57

How do I cancel my Imbue membership?

Accepted Answer

Cancel from your account portal in two clicks, or email support@tryimbue.com. There is no separate medication subscription to cancel — when you cancel the membership, future prescriptions are no longer issued. You retain any medication already shipped from NovoCare or LillyDirect.

Question 58

Why is the membership separate from medication cost?

Accepted Answer

Separating the two keeps your membership low and gives you flexibility. You're not locked into a bundled price, and if you pause or switch medications, your physician care continues uninterrupted at $29/mo — the price doesn't change.

Question 59

Are there any hidden fees or contracts?

Accepted Answer

No. You pay $29/mo for your membership — the same in month twelve as in month one — and the listed price for your medication. That's it. There are no enrollment fees, no cancellation penalties, and no long-term commitments.

Question 60

Do you accept insurance?

Accepted Answer

No. Imbue Health is a cash-pay service — we do not bill insurance for the membership or for medications purchased through our partner pharmacy programs (NovoCare and LillyDirect).

Question 61

What payment methods do you accept?

Accepted Answer

We accept all major credit cards and debit cards for the membership. Medication payment is handled directly through NovoCare or LillyDirect during the fulfillment process.

Question 62

What happens if I want to cancel?

Accepted Answer

Cancel anytime from your account — no phone calls, no penalties. Your care continues through the end of your current billing period.

Question 63

What happens if my insurance denies Wegovy® or Zepbound®?

Accepted Answer

Imbue is built for cash-pay patients. If insurance denies coverage, your Imbue physician writes the prescription directly to NovoCare Pharmacy or LillyDirect, where you pay the published manufacturer cash-pay price ($199–$499/mo depending on medication and dose). There is no surprise pricing, prior-auth wait, or denial loop. See our full Insurance & GLP-1 Coverage guide.

Question 64

Should I get a GLP-1 through telehealth or in-person care?

Accepted Answer

Telehealth advantages: faster prescription (often 1–3 days), lower cost when paying cash, all 50 states, no travel time. In-person advantages: complex comorbidities, integrated PCP relationship, in-house labs. Imbue is appropriate for patients who already have an established PCP for general care and want a focused, transparent, brand-name GLP-1 channel.

Frequently Asked Questions

Still have questions?